Physics and imaging technology: nuclear medicine
Knowledge of the physics and imaging technology involved in the production of nuclear medicine scans is vitally important for medical imaging specialists.
See also
- physics and imaging technology: x-ray
- physics and imaging technology: ultrasound
- physics and imaging technology: CT
- physics and imaging technology: MRI
- physics and imaging technology: nuclear medicine
Related Radiopaedia articles
Physics and imaging technology: nuclear medicine
- nuclear medicine physics
- detectors
- scintillation detectors (gamma camera)
- emission tomography
- radiopharmaceuticals
- fundamentals of radiopharmaceuticals
- radiopharmaceutical labeling
- radiopharmaceutical production
- nuclear reactor produced radionuclides
- cyclotron produced radionuclides
- radiation detection
- dosimetry
- specific agents
- carbon-11
- chromium-51
- fluorine agents
- gallium agents
- Ga-67 citrate
- Ga-68
- iodine agents
- I-123
- I-123 iodide
- I-123 ioflupane (DaTSCAN)
- I-123 ortho-iodohippurate
- I-131
- MIBG scans
- I-123 MIBG
- I-131 MIBG
- I-123
- indium agents
- In-111 Octreoscan
- In-111 OncoScint
- In-111 Prostascint
- In-111 oxine labeled WBC
- krypton-81m
- nitrogen-13
- oxygen-15
- phosphorus-32
- selenium-75
- technetium agents
- Tc-99m DMSA
- Tc-99m DTPA
- Tc-99m DTPA aerosol
- Tc-99m HMPAO
- Tc-99m HMPAO labeled WBC
- Tc-99m MAA
- Tc-99m MAG3
- Tc-99m MDP
- Tc-99m mercaptoacetyltriglycine
- Tc-99m pertechnetate
- Tc-99m labeled RBC
- Tc-99m sestamibi
- Tc-99m sulfur colloid
- Tc-99m sulfur colloid (oral)
- thallium-201 chloride
- xenon agents
- in vivo therapeutic agents
- erbium-169
- samarium-153
- strontium-89
- yttrium-90
- pharmaceuticals used in nuclear medicine
